Prohibitive expenses delay crucial treatments and drive up healthcare costs.
Inflexible protocols prevent adaptation to important emerging data patterns.
Lengthy phase-by-phase testing extends time-to-market by years, delaying patient access.
Participants fear receiving placebos and struggle with disconnected care coordination.
2
- Electronic medical records systems prioritize billing over patient care coordination
- Delayed treatment protocols significantly increase patient mortality rates
- Escalating physician burnout from overwhelming administrative requirements
- Critical specialty care shortages creating healthcare deserts in vulnerable communities
3
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Physicians Unified Library for Sharing Electronic Records transforms how clinical research is conducted and shared globally.
Our groundbreaking technology slashes clinical trial expenses by 30-70%, making research more accessible and sustainable.
PULSER delivers sophisticated Data Management Services designed specifically for clinical research, not direct healthcare delivery.
Multi-factor authentication and advanced encryption protocols ensure data integrity while providing secure, password-protected access for authorized researchers only.
4
Sophisticated mathematical algorithms integrated with natural language processing operate continuously across electronic medical record networks, extracting valuable insights in real-time.
Seamlessly integrates umbrella, basket, and platform methodologies into a unified clinical trial framework, enabling adaptive course-correction based on predictive analytics.
Expanded data collection drives exponential improvements in statistical optimization, enhances simulation accuracy, and delivers superior outcomes across all trial arms simultaneously.
5
Transforms unstructured clinical narratives into structured medical data from expert EMRs
Integrates patient data across hospital systems enabling powerful predictive analytics
Performs real-time analysis to identify patterns and deliver timely clinical alerts
Employs mathematical models to identify significant outcomes earlier
6
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Continuously captures vital patient metrics and population trends with unprecedented precision
Utilizes AI-generated control groups, enabling more patients to receive potentially beneficial treatments
Converts complex medical information into strategic insights that accelerate treatment discoveries
7
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
$50B+ Allocated by biopharmaceutical companies for US clinical research initiatives
$41,117 Median expenditure per participant in critical Phase 3 pivotal studies
$35M Typical cost required for moderate to large-scale Phase 1-3 clinical evaluations
8
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Full-scale monetization across clinical trial phases 1-4
Projected share from trial budgets for data analytics
Enabling faster regulatory pathways while reducing costs
Revenue sharing from novel applications identified through our platform
9
Constructing sophisticated AI algorithms and robust mathematical modeling framework
Seamlessly connecting with electronic medical record systems across healthcare networks
Launching strategic clinical trials with pharmaceutical partners for real-world validation
Accelerating adoption across diverse therapeutic domains and international healthcare markets
10
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Chief Executive Officer & Chief Medical Officer
Distinguished Infectious Disease & Internal Medicine specialist with extensive experience at UCLA, Veterans Affairs, and Providence St. Joseph Health
Strategic, Business, and Ethics Counsel
Managing Partner at Maranga-Morgenstern Law Corporation; Board Member of White Memorial Medical Center
Clinical Research Director
Pharmaceutical executive with leadership expertise in virology and clinical research; former Vice President of Virology Medical Affairs at Bristol-Myers Squibb
11
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Our expert team brings world-class experience in mathematics, AI, and business strategy.
Head of Data Science
Distinguished Computer Scientist, Neurophysiologist, and Mathematician with extensive research at DARPA, Department of Defense, and National Institutes of Health
Advanced Mathematics
Caltech-educated Mathematician specializing in Artificial Intelligence, Natural Language Processing, and Software and Systems Analysis
Chief Business Officer
Accomplished CEO of Turn Therapeutics with proven expertise in Strategic Marketing, Business Development, and Securing Investment Capital
12
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Department of Computational Medicine & Bioinformatics
Distinguished Professor of Psychiatry at University of Michigan Medical School with extensive research in biomedical informatics and computational biology
Seasoned healthcare IT executive specializing in enterprise cybersecurity architecture, secure data center operations, and regulatory compliance
Expert in implementing HIPAA/CMMC frameworks for protected health information security
13
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
Strategic convertible note with favorable terms for early investors
Investing in robust, scalable technology infrastructure with advanced analytics capabilities
Recruiting specialized technical talent and clinical experts with proven industry experience
Establishing strategic clinical trial collaborations with leading research institutions
Implementing enterprise-grade encryption and multi-factor authentication to protect sensitive investor and clinical data
14
invest@pulsernetwork.com | www.PulserNetwork.com | (877) 4-PULSE-AI
"Medicine is a science of uncertainty and an art of probability."
~Sir William Osler MD, Father of Modern Medicine
Request our detailed investor prospectus
Become a catalyst in revolutionizing clinical research methods
Accelerate breakthrough treatments to patients who need them most
invest@pulsernetwork.com
www.PulserNetwork.com
(877) 4-PULSE-AI
15
Our groundbreaking methodology transforms clinical trials and patient care delivery, dramatically reducing costs by 30-70% while accelerating timelines and saving countless lives.